Cognition AI Inc. is in early talks to raise a new round of funding that would more than double its valuation to $25 billion, ...
Company’s memory precision assessment, “PREMAZ,” detects subtle cognitive changes years before traditional tests, ...
Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that a second philanthropic ...
Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the ongoing pursuit by psychology ...
Artificial-intelligence coding startup Cognition is expanding across Asia, looking to plug a “software deficit” with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results